JK

John T. Kilcoyne

Non-Executive Director at Cerus Endovascular

market to the Cerus Endovascular Board. Mr. Kilcoyne is currently the CEO of JenaValve. Prior to his role at JenaValve, Mr. Kilcoyne was Chief Executive Officer of ReVision Optics. Prior to ReVision Optics, he served as chief executive officer and chairman of Micrus Endovascular, which he took public and then successfully led for six years until its sale to Johnson & Johnson in 2010.

From 2002 to 2004, he served as president and chief executive officer of medical device company Solace Therapeutics. Prior to Solace, he served as the president and chief executive officer of Endonetics, Inc. until its acquisition by Medtronic in 2001. Mr. Kilcoyne received his B.S. from Cornell University.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


  1. This content is no longer available.